Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Sep 2;15(17):4395. doi: 10.3390/cancers15174395

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

(a) These graphs show the cumulative incidence of patients presented at the MDT/SBs over a 15-month period, according to anatomic location of the tumor. (b) These graphs show the cumulative incidence of the patients presented at the MDT/SBs over a 15-month period, according to dignity of the tumors. (c) This graph shows the cumulative indications of patients presented at the MDT/SB-A over a 15-month period, according to the performed therapy. (d) This graph shows the cumulative indications of patients presented at the MDT/SB-Bs over a 15-month period, according to the performed therapy.

(a) These graphs show the cumulative incidence of patients presented at the MDT/SBs over a 15-month period, according to anatomic location of the tumor. (b) These graphs show the cumulative incidence of the patients presented at the MDT/SBs over a 15-month period, according to dignity of the tumors. (c) This graph shows the cumulative indications of patients presented at the MDT/SB-A over a 15-month period, according to the performed therapy. (d) This graph shows the cumulative indications of patients presented at the MDT/SB-Bs over a 15-month period, according to the performed therapy.